
AI Revenue Is Not Value — And ‘95% Failure’ Misses The Real Story
Current AI debates regarding booming vendor revenue and high failure rates miss the real question of: Who is actually getting value from AI? In thi...

AI-Driven Drug Approval Propels Pharos iBio Shares to New Heights
Pharos iBio, a pharmaceutical company specializing in AI-driven drug development, witnessed a significant surge in its shares after announcing the ...